Evaluation Of The Importance Of Risk-Factor Adjustment For Assessing The Relationship Between Voriconazole Utilization And The Development Of Non-Melanoma Skin Cancer Among Lung And Heart/Lung Transplant Patients, 2002-2009g

Clinical trial NCT01480219 · COMPLETED

Trial details

NCT number: NCT01480219
Sponsor: Pfizer
Status: COMPLETED
Study type: OBSERVATIONAL

Non-Melanoma Skin Carcinoma

Start date: 2011-08-01
Primary completion: 2012-03-01
Enrollment: 467

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.